Updated Jul 16, 2026
Gabay Avraham has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $331K.
Avraham Gabay is the Chief Financial Officer of Oramed Pharmaceuticals Inc., a company focused on the oral delivery of therapeutic proteins. He has been involved in the company's financial operations, but there is limited public information available regarding his career and achievements.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | ORMP | ORAMED PHARMACEUTICALS INC. | S — Open-market sale | 73.4K | $4.51 | $331K |
| 2026-03-18 | ORMP | ORAMED PHARMACEUTICALS INC. | A — Grant or award | 95.9K | $0.00 | |
| 2026-01-29 | ORMP | ORAMED PHARMACEUTICALS INC. | M — Option exercise | 19.0K | $0.00 | |
| 2026-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | A — Grant or award | 115.0K | $0.00 | |
| 2026-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | A — Grant or award | 81.2K | $0.00 | |
| 2024-11-08 | ORMP | ORAMED PHARMACEUTICALS INC. | A — Grant or award | 30.0K | — |
Avraham Gabay is the Chief Financial Officer of Oramed Pharmaceuticals Inc., a company focused on the oral delivery of therapeutic proteins. He has been involved in the company's financial operations, but there is limited public information available regarding his career and achievements.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($331K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Gabay Avraham profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.